-Reuters
MiNK Therapeutics Announces Preclinical Activity Of MiNK-215 Against Colorectal Cancer Liver Metastases At AACR
MiNK-215 eliminated MSS colorectal cancer liver metastases in human organoid models MiNK-215 exhibits potent anti-tumor activity through multiple mechanisms including immune activation NEW YORK, April 08, 2024